Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

NZ dollar's wings clipped, RBNZ tipped to go 50bps
Economy

NZ dollar's wings clipped, RBNZ tipped to go 50bps

The kiwi is sliding, but it is more about the greenback than the RBNZ. 

NZ market rises on potential for more Chinese stimulus
Markets Market Close

NZ market rises on potential for more Chinese stimulus

Overnight US bond yields were down.

Graham Skellern 04 Oct 2024
Blackpearl seeks $10m to help win higher-value customers
Markets

Blackpearl seeks $10m to help win higher-value customers

The NZX-listed company’s customers are primarily US-based.

Ben Moore 04 Oct 2024